成年人便失禁:新的治疗方法
John W Blackett1, Adil E Bharucha2
1Division of Digestive and Liver Diseases, Columbia University, New York, New York, USA.
The American journal of gastroenterology
|March 13, 2025
概括
便失禁 (FI) 影响全球8%,影响福祉和财务. 管理需要量身定制的保守和先进疗法,以神经神经调节作为首选的外科选择.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 盆地床医学 盆地床医学
背景情况:
- 便失禁 (FI) 是一种普遍的疾病,影响全球约8%的人口.
- 药物治疗对患者的身体,社会和经济福祉产生重大影响.
- 风险因素包括年龄,腹,关节损伤,盆地问题,IBD和神经疾病.
研究的目的:
- 审查目前对便失禁的理解.
- 讨论诊断技术和可用的治疗选择.
- 突出需要一致的管理策略.
主要方法:
- 审查关于便不的流行,危险因素和管理现有文献.
- 分析保守的,最少的侵入性和手术治疗方式.
- 对各种治疗干预措施的证据评估.
主要成果:
- 保守的治疗方法 (饮食,纤维,PT) 当量身定制并严格应用时是有益的.
- 直肠生物反,注射剂和屏障装置提供了下一层次的选择.
- 圣神经调节是首选的手术治疗; 其他神经刺激显示混合的结果; 膜整形术和大肠切除术是专门为特定情况下保留的.
结论:
- 尽管取得了进展,但FI管理仍然不一致,原因是对治疗方法的认识有限.
- 量身定制的保守和先进治疗,包括神经神经调节,对于有效的FI管理至关重要.
- 对于新兴疗法,如自身肌肉细胞注射,需要进一步的研究.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133
Inflammatory Bowel Disease V: Surgical Management
77
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
77
Irritable Bowel Syndrome III: Medical and Nursing Management
133
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
133
Drugs Affecting GI Tract Motility: Other Laxatives
143
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
143
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
153
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
153


